These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19180343)

  • 1. Noncigarette forms of tobacco use.
    Viegas CA
    J Bras Pneumol; 2008 Dec; 34(12):1069-73. PubMed ID: 19180343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smokeless tobacco, sport and the heart.
    Chagué F; Guenancia C; Gudjoncik A; Moreau D; Cottin Y; Zeller M
    Arch Cardiovasc Dis; 2015 Jan; 108(1):75-83. PubMed ID: 25497687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal snuff: historical review and health related aspects.
    Sapundzhiev N; Werner JA
    J Laryngol Otol; 2003 Sep; 117(9):686-91. PubMed ID: 14561353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissent over harm reduction for tobacco.
    Gray N; Henningfield J
    Lancet; 2006 Sep; 368(9539):899-901. PubMed ID: 16962864
    [No Abstract]   [Full Text] [Related]  

  • 5. Tobacco smoking, harm reduction, and nicotine product regulation.
    Britton J; Edwards R
    Lancet; 2008 Feb; 371(9610):441-5. PubMed ID: 17920116
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic nicotine effects on left ventricular function in healthy middle-aged people: an echocardiographic study.
    Sundström D; Waldenborg M; Magnuson A; Emilsson K
    Clin Physiol Funct Imaging; 2013 Jul; 33(4):317-24. PubMed ID: 23692623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Snuff, nicotine and cardiovascular disease: implications for tobacco control.
    Benowitz NL
    J Am Coll Cardiol; 1999 Nov; 34(6):1791-3. PubMed ID: 10577571
    [No Abstract]   [Full Text] [Related]  

  • 8. [Risk reduction strategies in smoking].
    Martinet Y; Bohadana A; Wirth N; Spinosa A; Béguinot E
    Rev Mal Respir; 2006 Sep; 23(4 Suppl):13S109-18; quiz 13S158, 13S159. PubMed ID: 17057636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter to the editor in response to "An epidemic that deserves more attention: epidemiology, prevention, and treatment of smokeless tobacco".
    Phillips CV; Heavner KK
    South Med J; 2008 Feb; 101(2):211; author reply 211-2. PubMed ID: 18364630
    [No Abstract]   [Full Text] [Related]  

  • 10. Passive smoking and the use of noncigarette tobacco products in association with risk for pancreatic cancer: a case-control study.
    Hassan MM; Abbruzzese JL; Bondy ML; Wolff RA; Vauthey JN; Pisters PW; Evans DB; Khan R; Lenzi R; Jiao L; Li D
    Cancer; 2007 Jun; 109(12):2547-56. PubMed ID: 17492688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smokeless tobacco: the health consequences of snuff and chewing tobacco.
    Goolsby MJ
    Nurse Pract; 1992 Jan; 17(1):24, 28, 31, passim. PubMed ID: 1538836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of nicotine in dust from homes of smokeless tobacco users.
    Whitehead TP; Metayer C; Park JS; Does M; Buffler PA; Rappaport SM
    Nicotine Tob Res; 2013 Dec; 15(12):2045-52. PubMed ID: 23884321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tobacco product regulation: context and issues.
    Slade J; Henningfield JE
    Food Drug Law J; 1998; 53 suppl():43-74. PubMed ID: 10342980
    [No Abstract]   [Full Text] [Related]  

  • 14. Randomised clinical trial of snus versus medicinal nicotine among smokers interested in product switching.
    Hatsukami DK; Severson H; Anderson A; Vogel RI; Jensen J; Broadbent B; Murphy SE; Carmella S; Hecht SS
    Tob Control; 2016 May; 25(3):267-74. PubMed ID: 25991608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E-cigarettes and cardiovascular risk: beyond science and mysticism.
    Lippi G; Favaloro EJ; Meschi T; Mattiuzzi C; Borghi L; Cervellin G
    Semin Thromb Hemost; 2014 Feb; 40(1):60-5. PubMed ID: 24343348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Snuffing out cigarette sales and the smoking deaths epidemic.
    Laugesen M
    N Z Med J; 2007 Jun; 120(1256):U2587. PubMed ID: 17589555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smokeless tobacco: an addicting drug.
    Henningfield JE; Fant RV; Tomar SL
    Adv Dent Res; 1997 Sep; 11(3):330-5. PubMed ID: 9524433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic and cardiovascular effects of smokeless tobacco.
    Arabi Z
    J Cardiometab Syndr; 2006; 1(5):345-50. PubMed ID: 17679792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smokeless tobacco or nicotine replacement therapy has no effect on serum immunoglobulin levels.
    Gyllén P; Andersson BA; Qvarfordt I
    Respir Med; 2004 Feb; 98(2):108-14. PubMed ID: 14971872
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.